What Is BPC-157?
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide — a chain of 15 amino acids — derived from a partial sequence of human gastric juice protein. Its molecular formula is C₆₂H₉₈N₁₆O₂₂, with a molecular weight of approximately 1,419 Da.
The compound was first isolated and characterized in the early 1990s as part of investigations into endogenous protective factors present in gastric secretions. Unlike longer peptide chains, BPC-157 was noted for its stability under physiological conditions — an uncommon property that has made it a subject of ongoing preclinical inquiry.
Research Use Only: All information in this article is intended for educational and scientific reference purposes. BPC-157 is not approved for human use and is available exclusively as a laboratory research compound.
Molecular Structure and Stability
BPC-157 carries the amino acid sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Its relative stability compared to other peptides of similar length has been a notable feature in research contexts. Many peptides degrade rapidly in acidic gastric environments, yet BPC-157 has demonstrated resistance to enzymatic hydrolysis in several in vitro studies — a property that distinguishes it mechanistically from short-lived secretagogues.
From a storage and handling standpoint, lyophilized BPC-157 is typically stable when maintained at −20 °C in a dry, sealed environment, with reconstituted solutions used promptly after preparation. Standard laboratory practice calls for sterile bacteriostatic water as a reconstitution solvent, stored at 4 °C for short-term use.
Areas of Preclinical Research Interest
Angiogenesis Pathways
A recurring theme in published BPC-157 preclinical literature is its apparent relationship with angiogenic signaling. Multiple rodent-model studies have explored its effects on vascular endothelial growth factor (VEGF) expression and related downstream pathways. Researchers have examined whether these interactions contribute to observations of increased microvessel density in treated tissue samples.
The angiogenic angle has made BPC-157 of interest to investigators studying wound-site biology, where adequate vascular supply is a rate-limiting factor in tissue remodeling.
Fibroblast Activity
In cell culture and rodent models, BPC-157 has been associated with changes in fibroblast behavior, including migration and proliferation rates. Fibroblasts are central to extracellular matrix deposition and are a key cell type studied in connective tissue research. In vitro models have examined whether BPC-157 affects collagen synthesis pathways, though translational implications remain under investigation.
Gastrointestinal Mucosal Studies
Given its origin in gastric secretions research, BPC-157 has been most extensively studied in gastrointestinal models. Published literature describes rodent experiments exploring its interaction with gastrointestinal mucosal integrity under various stress conditions. Researchers have used these models to examine cytoprotective mechanisms including interactions with prostaglandin systems and nitric oxide pathways.
Tendon and Ligament Models
A subset of BPC-157 research has focused on musculoskeletal tissue biology. Rat models with surgically induced tendon and ligament disruptions have been used to study cellular proliferation and collagen fiber organization in treated vs. control groups. Several studies have used histological analysis to quantify differences in tissue architecture.
Research Publications at a Glance
The majority of peer-reviewed work on BPC-157 originates from the laboratory of Dr. Predrag Sikirić at the University of Zagreb. Over 100 papers have been published in journals including Current Pharmaceutical Design, Journal of Physiology-Paris, and Biomolecules.
A 2021 review in Biomolecules summarized preclinical findings across multiple organ systems, noting that while in vitro and small-animal data are extensive, human clinical trial data remain absent from the published literature at this time. The review characterized BPC-157 as a compound with "promising but preliminary" preclinical signals that warrant further controlled investigation.
Quality and Purity Considerations for Research Use
For laboratory researchers, compound purity is a foundational consideration. BPC-157 synthesized via solid-phase peptide synthesis (SPPS) should be verified by:
- HPLC analysis — confirms purity percentage and identifies any synthesis byproducts
- Mass spectrometry — validates correct molecular weight and sequence identity
- Amino acid analysis — quantitative confirmation of residue composition
Reputable research suppliers provide batch-specific Certificates of Analysis (COA) with these data points. When evaluating BPC-157 for research use, confirm that HPLC purity is documented at ≥98% and that the mass spec data matches the expected molecular weight of 1,419 Da.
Regulatory Status
BPC-157 is not approved by the FDA, EMA, or any major regulatory body as a drug, medical device, or dietary supplement. It is classified as a research chemical in most jurisdictions and is legally available only for in vitro and animal model research conducted by qualified investigators in appropriate laboratory settings.
Researchers should confirm applicable local, state, and federal regulations before acquisition and ensure proper institutional oversight (IACUC approval for animal research, IRB for human subjects work) is in place.
Conclusion
BPC-157 occupies a unique position in the peptide research landscape: a relatively stable pentadecapeptide with an unusually wide preclinical literature base, spanning gastrointestinal, musculoskeletal, angiogenic, and neurological models. Its lack of clinical trial data in humans means its utility and safety for any human application remain unknown.
For researchers operating in appropriate laboratory settings, BPC-157 represents a well-documented preclinical research tool with active investigation ongoing across multiple university and institutional programs.
All products referenced on this site are sold for laboratory research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.